Related Experiment Video
Updated: Jun 19, 2026

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
Toll-like receptor 2 dependent immunogenicity of glycoconjugate vaccines containing chemically derived zwitterionic
Simona Gallorini1, Francesco Berti, Giuseppe Mancuso
1Novartis Vaccines Research Center, Via Fiorentina 1, 53100 Siena, Italy.
Insights
Zwitterionic polysaccharides (ZPS) create potent vaccines by activating antigen-presenting cells (APCs) via toll-like receptor 2 (TLR2). These ZPS-glycoconjugates enhance immune responses and protection against Group B Streptococcus (GBS) infection.
Area of Science:
- Vaccinology
- Immunology
- Biochemistry
Background:
- Group B Streptococcus (GBS) poses a significant threat to neonates, necessitating effective vaccine development.
- Current vaccine strategies often require separate antigen and adjuvant components.
- Zwitterionic polysaccharides (ZPS) derived from GBS exhibit intrinsic immunomodulatory properties.
Purpose of the Study:
- To develop a novel vaccine platform combining antigen and adjuvant functions in a single molecule.
- To investigate the immunogenicity and protective efficacy of ZPS-based glycoconjugates.
- To elucidate the role of toll-like receptor 2 (TLR2) in ZPS-mediated immune activation.
Main Methods:
- Chemical modification of GBS anionic polysaccharides to create zwitterionic polysaccharides (ZPS).
- Conjugation of ZPS with carrier proteins to form ZPS-glycoconjugates.
- Assessment of immune responses (T-cell and antibody titers) and protection in mouse models, including TLR2 knockout mice.
- Evaluation of ZPS as standalone adjuvants with unrelated antigens.
Main Results:
- ZPS-glycoconjugates elicited significantly higher T-cell and antibody responses compared to native polysaccharide-glycoconjugates.
- ZPS-conjugates demonstrated enhanced activation of dendritic cells (DCs), correlating with increased immunogenicity.
- Vaccination with ZPS-conjugates provided superior protection against lethal GBS challenge in mothers and neonates.
- The immunomodulatory and protective effects of ZPS were dependent on TLR2 signaling.
- ZPS co-administered with tetanus toxoid boosted specific antibody titers.
Conclusions:
- Glycoconjugates incorporating ZPS represent potent vaccine candidates with inherent adjuvant properties.
- ZPS function by targeting antigens to TLR2-expressing APCs, thereby enhancing adaptive immunity.
- Rational chemical design of ZPS offers a versatile strategy for developing advanced polysaccharide-based vaccines and adjuvants.
Abstract:
Group B Streptococcus (GBS) causes serious infection in neonates and is an important target of vaccine development. Zwitterionic polysaccharides (ZPS), obtained through chemical introduction of positive charges into anionic polysaccharides (PS) from GBS, have the ability to activate human and mouse antigen presenting cells (APCs) through toll-like receptor 2 (TLR2). To generate a polysaccharide vaccine with antigen (Ag) and adjuvant properties in one molecule, we have conjugated ZPS with a carrier protein. ZPS-glycoconjugates induce higher T-cell and Ab responses to carrier and PS, respectively, compared to control PS-glycoconjugates made with the native polysaccharide form. The increased immunogenicity of ZPS-conjugates correlates with their ability to activate dendritic cells (DCs). Moreover, protection of mothers or neonate offspring from lethal GBS challenge is better when mothers are immunized with ZPS-conjugates compared to immunization with PS-conjugates. In TLR2 knockout mice, ZPS-conjugates lose both their increased immunogenicity and protective effect after vaccination. When ZPS are coadministered as adjuvants with unconjugated tetanus toxoid (TT), they have the ability to increase the TT-specific antibody titer. In conclusion, glycoconjugates containing ZPS are potent vaccines. They target Ag to TLR2-expressing APCs and activate these APCs, leading to better T-cell priming and ultimately to higher protective Ab titers. Thus, rational chemical design can generate potent PS-adjuvants with wide application, including glycoconjugates and coadministration with unrelated protein Ags.
More Related Videos
12:53Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
Published on: March 16, 2022
10:35Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo
Published on: February 5, 2021
Related Concept Videos
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Proteoglycans
Protein Glycosylation
Glycosylation occurs in...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...